Company: GCTS
Filing Date: 2025-05-30
Form Type: S-3/A
Source: 0001104659-25-054969
Chunk: 15

Company: GCT Semiconductor Holding, Inc.
Filing Date: 2025-05-30
Form: S-3/A
Chunk 15
---
 described
in the “Risk Factors” section. The risks described in “Risk Factors” are not exhaustive. These forward-looking
statements are based on information available as of the date of this prospectus, and current expectations, forecasts and assumptions,
and involve a number of judgments, risks and uncertainties. New risk factors emerge from time to time and it is not possible for us to
predict all such risk factors, nor can we assess the impact of all such risk factors on our business or the extent to which any factor
or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements. All forward-looking
statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing cautionary statements.
We undertake no obligations to update or revise publicly any forward-looking statements, whether as a result of new information, future
events or otherwise, except as required by law.

<div align='center'>USE OF PROCEEDS</div>

All of the securities offered
by the Selling Securityholders pursuant to this prospectus will be sold by the Selling Securityholders for their respective accounts.
We could receive up to an aggregate of approximately $103,317,920 if all of the Warrants held by the Selling Securityholders are exercised
for cash. Unless we inform you otherwise in a prospectus supplement or free writing prospectus, we intend to use the net proceeds from
the exercise of such Warrants for general corporate purposes, including, but not limited to, working capital for operations, capital expenditures
and future acquisitions. However, we will only receive such proceeds if and when the holders of the Warrants exercise the Warrants for
cash. The exercise of the Warrants, and any proceeds we may receive from their exercise, are highly dependent on the price of any of our
shares of Common Stock and the spread between the exercise price of the Warrants and the price of our Common Stock at the time of exercise.
We have outstanding (i) 17,250,000 Public Warrants to purchase 17,250,000 shares of our Common Stock, exercisable at an exercise
price of $11.50 per share, (ii) 6,580,000 Private Placement Warrants to purchase 6,580,000 shares of our Common Stock, exercisable
at an exercise price of $11.50 per share, (iii) 2,295,333 GCT Warrants to purchase 2,295,333 shares of our Common Stock, exercisable